Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 11.41% is 28% above its 5-year average of 8.90%, around the middle of its 5-year range (-7.15%–21.61%).
As of the fiscal period ended Tuesday, March 31, 2026. 23.88% above its 12-month average of 9.21%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
11.41%
NET PROFIT MARGIN AVG TTM
9.21%
NET PROFIT MARGIN AVG 3Y
10.53%
NET PROFIT MARGIN AVG 5Y
10.33%
NET PROFIT MARGIN AVG 10Y
9.82%
NET PROFIT MARGIN AVG 15Y
11.64%
NET PROFIT MARGIN AVG 20Y
13.65%
CURRENT VS TTM AVG
+23.88%
CURRENT VS 3Y AVG
+8.36%
CURRENT VS 5Y AVG
+10.43%
CURRENT VS 10Y AVG
+16.17%
CURRENT VS 15Y AVG
-1.94%
CURRENT VS 20Y AVG
-16.41%
SECTOR MEDIAN · HEALTHCARE
9.05%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+26.08%
vs the sector median at left
Zimmer Biomet Holdings, Inc.
Market Cap
$18.37B
Net Profit Margin
11.41%
TTM Avg
9.21%
3Y Avg
10.53%
5Y Avg
10.33%
Market Cap
$16.97B
Net Profit Margin
13.18%
TTM Avg
16.70%
3Y Avg
17.87%
5Y Avg
22.37%
Market Cap
$20.33B
Net Profit Margin
-2.04%
TTM Avg
-14.44%
3Y Avg
-3.94%
5Y Avg
-4.74%
Market Cap
$15.90B
Net Profit Margin
17.67%
TTM Avg
18.50%
3Y Avg
17.20%
5Y Avg
16.74%
Market Cap
$15.12B
Net Profit Margin
17.33%
TTM Avg
12.25%
3Y Avg
14.36%
5Y Avg
15.15%
Market Cap
$21.96B
Net Profit Margin
40.61%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
Market Cap
$22.44B
Net Profit Margin
-141.43%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
Market Cap
$14.40B
Net Profit Margin
5.57%
TTM Avg
9.62%
3Y Avg
9.77%
5Y Avg
24.94%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.37B | 11.41% | 9.21% | 10.53% | 10.33% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 13.18% | 16.70% | 17.87% | 22.37% |
| Viatris Inc. (VTRS)vs › | $20.33B | -2.04% | -14.44% | -3.94% | -4.74% |
| Medpace Holdings, Inc. (MEDP)vs › | $15.90B | 17.67% | 18.50% | 17.20% | 16.74% |
| Solventum Corporation (SOLV)vs › | $15.12B | 17.33% | 12.25% | 14.36% | 15.15% |
| United Therapeutics Corporation (UTHR)vs › | $21.96B | 40.61% | 41.73% | 40.84% | 37.71% |
| DaVita Inc. (DVA)vs › | $14.78B | 5.65% | 6.39% | 5.83% | 6.41% |
| Moderna, Inc. (MRNA)vs › | $22.44B | -141.43% | -128.24% | -70.25% | -50.87% |
| The Cooper Companies, Inc. (COO)vs › | $14.40B | 5.57% | 9.62% | 9.77% | 24.94% |
| Baxter International Inc. (BAX)vs › | $14.35B | -9.27% | -7.30% | -3.29% | 1.14% |
Operating Margin
15.6%
Net Profit Margin
11.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 11.41% |
| 2025-12-31 | 6.22% |
| 2025-09-30 | 11.54% |
| 2025-06-30 | 7.36% |
| 2025-03-31 | 9.53% |
| 2024-12-31 | 11.84% |
| 2024-09-30 | 13.66% |
| 2024-06-30 | 12.50% |
| 2024-03-31 | 9.13% |
| 2023-12-31 | 21.61% |
| 2023-09-30 | 9.28% |
| 2023-06-30 | 11.21% |
| 2023-03-31 | 12.70% |
| 2022-12-31 | -7.15% |
| 2022-09-30 | 11.62% |
| 2022-06-30 | 8.63% |
| 2022-03-31 | 0.85% |
| 2021-12-31 | -4.12% |
| 2021-09-30 | 8.64% |
| 2021-06-30 | 8.05% |
| 2021-03-31 | 12.37% |
| 2020-12-31 | 16.00% |
| 2020-09-30 | 12.57% |
| 2020-06-30 | -16.85% |
| 2020-03-31 | -28.51% |
| 2019-12-31 | 15.09% |
| 2019-09-30 | 22.78% |
| 2019-06-30 | 6.72% |
| 2019-03-31 | 12.46% |
| 2018-12-31 | -43.51% |
| 2018-09-30 | 8.83% |
| 2018-06-30 | 9.21% |
| 2018-03-31 | 8.66% |
| 2017-12-31 | 59.36% |
| 2017-09-30 | 5.45% |
| 2017-06-30 | 9.45% |
| 2017-03-31 | 15.18% |
| 2016-12-31 | 3.46% |
| 2016-09-30 | 8.66% |
| 2016-06-30 | -1.62% |
| 2016-03-31 | 5.71% |
| 2015-12-31 | 6.57% |
| 2015-09-30 | 1.26% |
| 2015-06-30 | -14.87% |
| 2015-03-31 | 15.11% |
| 2014-12-31 | 12.81% |
| 2014-09-30 | 15.65% |
| 2014-06-30 | 14.92% |
| 2014-03-31 | 19.07% |
| 2013-12-31 | 19.01% |
| 2013-09-30 | 14.37% |
| 2013-06-30 | 13.01% |
| 2013-03-31 | 19.19% |
| 2012-12-31 | 12.94% |
| 2012-09-30 | 17.37% |
| 2012-06-30 | 19.07% |
| 2012-03-31 | 18.37% |
| 2011-12-31 | 13.42% |
| 2011-09-30 | 18.57% |
| 2011-06-30 | 17.92% |
| 2011-03-31 | 18.73% |
| 2010-12-31 | 3.08% |
| 2010-09-30 | 19.80% |
| 2010-06-30 | 15.65% |
| 2010-03-31 | 19.33% |
| 2009-12-31 | 14.02% |
| 2009-09-30 | 15.36% |
| 2009-06-30 | 20.60% |
| 2009-03-31 | 20.37% |
| 2008-12-31 | 16.26% |
| 2008-09-30 | 22.55% |
| 2008-06-30 | 21.04% |
| 2008-03-31 | 22.59% |
| 2007-12-31 | 24.57% |
| 2007-09-30 | 4.93% |
| 2007-06-30 | 23.85% |
| 2007-03-31 | 24.56% |
| 2006-12-31 | 26.21% |
| 2006-09-30 | 22.36% |
| 2006-06-30 | 22.79% |
| 2006-03-31 | 23.90% |
| 2005-12-31 | 23.53% |
| 2005-09-30 | 22.11% |
| 2005-06-30 | 22.52% |
| 2005-03-31 | 20.95% |
| 2004-12-31 | 24.97% |
| 2004-09-30 | 18.27% |
| 2004-06-30 | 15.77% |
| 2004-03-31 | 13.15% |
| 2003-12-31 | 5.27% |
| 2003-09-30 | 21.35% |
| 2003-06-30 | 21.65% |
| 2003-03-31 | 34.68% |
| 2002-12-31 | 19.50% |
| 2002-09-30 | 19.29% |
| 2002-06-30 | 19.07% |
